CLINICAL_TRIALS
trial_result
· 2012-11-02
Clinical Trial Update: S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer [Phase 2]
Summary
Phase 2 trial S0312 evaluating gemcitabine plus capecitabine in patients with advanced renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED